October 9, 2020
Pfizer's palbociclib fails to extend survival in late-stage breast cancer study
Pfizer's palbociclib fails to extend survival in late-stage breast cancer study Source link
News I Health I Business I Life Hacks
Pfizer's palbociclib fails to extend survival in late-stage breast cancer study Source link